Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Chloro-6-methyl-2-(2-pyridinyl)pyrimidine is a crossover high spin ligand, with a mononuclear low spin transition state. This ligand has been shown to bind to the Fe site of the enzyme cytochrome c oxidase by forming an interaction with the heme and the protein. This interaction results in a hysteretic, isomeric ligand that binds reversibly to the Fe site. 4-Chloro-6-methyl-2-(2-pyridinyl)pyrimidine has been found to be autocatalytic in some cases, but this effect can be overcome by using a higher concentration of ligand.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-6-(methylsulfanyl)pyridine is an aromatic heterocyclic compound that contains a benzyl group and a pyridine ring. It has been used to synthesize 2,6-dichloropyrimidine nucleosides for the preparation of cytostatic drugs. This chemical compound has been shown to react with nucleophiles, such as hydroxide ion, through nucleophilic substitution reactions. This reaction is efficient and selective because the sulfinyl group can be removed by acid hydrolysis or hydrogenolysis and replaced with other functional groups. The pyridine ring is also unselective in these reactions because it can be reduced by lithium aluminum hydride to produce the corresponding amine.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Phenylthiomorpholine is a drug that is used as an antiarrhythmic agent. This drug has been shown to be effective in the treatment of arrhythmias and can be used to decrease the frequency of ventricular tachycardia, ventricular fibrillation, and atrial fibrillation. 2-Phenylthiomorpholine inhibits the activity of cysteamine, which is an amino acid that plays a major role in the regulation of blood pressure. It also has anti-inflammatory properties due to its ability to inhibit prostaglandin synthesis, as well as analgesic effects due to its activity on ligand-gated ion channels.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Ethyl 1-benzylpiperidine-2-carboxylate is an organic compound that belongs to the class of benzhydryl compounds. It is a colorless liquid at room temperature and has a boiling point of 60°C. Ethyl 1-benzylpiperidine-2-carboxylate can be synthesized by reacting methanol with piperidine in the presence of aluminum chloride and sodium borohydride in a catalytic amount. The nitrogen atom in this compound is a chiral center, which means it cannot exist as two enantiomers. This product also reacts with chloride to form ethylmagnesium chloride, which is used for the production of aminoalcohols.</p>

<p>Ethyl pipecolinate hydrochloride (EPH) is a stereoselective compound that inhibits aminopyrine N-demethylase and acetylcholinesterase. It has been shown to be effective in treating Alzheimer's disease and environmental pollution, as well as the inhibition of ovary cells. EPH is an alkynylated analog of pipecolic acid. This molecule contains a chiral center at the carbon atom adjacent to the amine group. The two possible enantiomers are called ethyl pipecolinate (EP) and ethyl diazoacetate (ED). EP is a more potent inhibitor of aminopyrine N-demethylase than ED, which inhibits acetylcholinesterase more effectively. The two compounds have been shown to be useful in the diagnosis of Parkinsonism and Alzheimer's disease by measuring their ability to inhibit acetylcholinesterase activity in vitro. Ethyl pipecolinate hydro</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Cyclohexyl cyanoacetate is an amide derivative and a pyrimidine derivative. It is used in pharmaceutical formulations as an intermediate for the synthesis of pyrazoles, which are used in the treatment of hyperproliferative disorders. Cyclohexyl cyanoacetate inhibits bacterial growth by inhibiting protein synthesis, as it binds to ribosomes and blocks the binding site for amino acids. Cyclohexyl cyanoacetate also has antifungal properties and is an acid catalyst.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Benzyloxy)butan-1-ol is a hydrazone compound that has been shown to have neuroprotective properties. It is an active compound that has been shown to inhibit the transport of glutamate into the cerebral cortex, and may be useful in the treatment of cerebral ischemia. 3-(Benzyloxy)butan-1-ol also binds to pharmacophores that are involved in the transport of carbamazepine, which may explain its ability to reduce neurotoxicity and increase the efficacy of carbamazepine. 3-(Benzyloxy)butan-1-ol is synthesized by reacting benzaldehyde with 2-hydroxybutanoic acid, giving a mixture of diastereomers. The diastereomers are separated by chromatography and then reduced with lithium aluminum hydride to give 3-(benzyloxy)butan-1-ol. The synthesis of this compound involves a number of steps that are not easily accomplished on</p>

<p>6-Bromo-2,3-dihydro-1H-indene-1-carboxylic acid is a synthetic drug that has anti-inflammatory properties. It is an acid derivative with analgesic and anticoagulant properties. It also has potential analgesic effects, since it inhibits the production of prostaglandins at sites of inflammation. 6Bromo-2,3-dihydro-1H-indene carboxylic acid also has biological activity against bacteria. Sulindac is a nonsteroidal antiinflammatory drug that was originally derived from this compound. 6Bromo-2,3-dihydro-1H indene carboxylic acid binds to DNA and inhibits transcription and translation by competitively inhibiting RNA polymerase and other DNA polymerases from binding to their respective DNA sequences. This drug is also found in the seeds of Anaphalis margaritacea L., which are</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>